Skip to main content

Regulation: The FDA is Overcautious on Consumer Genetics

Publication ,  Journal Article
Farahany, N; Green, R
Published in: Nature
2015

Duke Scholars

Published In

Nature

Publication Date

2015

Volume

505

Start / End Page

286 / 287

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Stress, Psychological
  • Humans
  • Hereditary Breast and Ovarian Cancer Syndrome
  • Genomics
  • Genetics, Medical
  • Genetic Testing
  • Genetic Counseling
  • Genes, BRCA1
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Farahany, N., & Green, R. (2015). Regulation: The FDA is Overcautious on Consumer Genetics. Nature, 505, 286–287.
Farahany, N., and R. Green. “Regulation: The FDA is Overcautious on Consumer Genetics.” Nature 505 (2015): 286–87.
Farahany N, Green R. Regulation: The FDA is Overcautious on Consumer Genetics. Nature. 2015;505:286–7.
Farahany, N., and R. Green. “Regulation: The FDA is Overcautious on Consumer Genetics.” Nature, vol. 505, 2015, pp. 286–87.
Farahany N, Green R. Regulation: The FDA is Overcautious on Consumer Genetics. Nature. 2015;505:286–287.

Published In

Nature

Publication Date

2015

Volume

505

Start / End Page

286 / 287

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Stress, Psychological
  • Humans
  • Hereditary Breast and Ovarian Cancer Syndrome
  • Genomics
  • Genetics, Medical
  • Genetic Testing
  • Genetic Counseling
  • Genes, BRCA1